Urine angiotensinogen and salt-sensitivity and potassium-sensitivity of blood pressure

Journal of Hypertension

Volumn 33, Issue 7, 2015, Pages 1394-1400

  Rebholz, Casey M ^a   Chen, Jing ^a,b   Zhao, Qi ^a   Chen, Ji Chun ^c   Li, Jianxin ^c   Cao, Jie ^c   Navar, Luis Gabriel ^b   Hamm, Lotuce Lee ^a,b   Gu, Dongfeng ^c   He, Jiang ^a,b  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FUWAI HOSPITAL   (China)

Author keywords

Angiotensinogen; Blood pressure; Dietary sodium; Hypertension; Renin angiotensin system; Salt sensitivity

Indexed keywords

ANGIOTENSINOGEN; CREATININE; POTASSIUM; SODIUM; SODIUM CHLORIDE; BIOLOGICAL MARKER; SALT INTAKE;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; DIASTOLIC BLOOD PRESSURE; EDUCATION; FEMALE; HIGH SODIUM INTAKE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICAL ACTIVITY; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SODIUM INTAKE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION; URINE LEVEL; ADVERSE EFFECTS; CHEMICALLY INDUCED; DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SODIUM RESTRICTION; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; ANGIOTENSINOGEN; BIOMARKERS; BLOOD PRESSURE; CREATININE; DIET, SODIUM-RESTRICTED; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POTASSIUM; RENIN-ANGIOTENSIN SYSTEM; SODIUM CHLORIDE, DIETARY; YOUNG ADULT;

EID: 84934771197     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000564     Document Type: Article

References (39)

1. Luft FC, Weinberger MH. Heterogeneous responses to changes in dietary salt intake: the salt-sensitivity paradigm. Am J Clin Nutr 1997; 65:612S-617S.
2. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension 1996; 27:481-490.
3. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 1997; 350:1734-1737.
4. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 2001; 37:429-432.
5. Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, et al. Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial. Ann InternMed 2001; 135:1019-1028.
6. He J, Gu D, Chen J, Jaquish CE, Rao DC, Hixson JE, et al. Gender difference in blood pressure responses to dietary sodium intervention in the gensalt study. J Hypertens 2009; 27:48-54.
7. Morris RC Jr, Sebastian A, Forman A, Tanaka M, Schmidlin O. Normotensive salt sensitivity: effects of race and dietary potassium. Hypertension 1999; 33:18-23.
8. Rebholz CM, Gu D, Chen J, Huang JF, Cao J, Chen JC, et al. Physical activity reduces salt sensitivity of blood pressure: the Genetic Epidemiology Network of Salt Sensitivity study. Am J Epidemiol 2012; 176 (Suppl 7):S106-S113.
9. Krishna GG. Effect of potassium intake on blood pressure. J Am Soc Nephrol 1990; 1:43-52.
10. Krishna GG, Chusid P, Hoeldtke RD. Mild potassium depletion provokes renal sodium retention. J Lab Clin Med 1987; 109:724-730.
11. Adrogue HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med 2007; 356:1966-1978.
12. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal reninangiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59:251-287.
13. Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002; 39: 316-322.
14. Ingert C, Grima M, Coquard C, Barthelmebs M, Imbs JL. Contribution of angiotensin II internalization to intrarenal angiotensin II levels in rats. Am J Physiol Renal Physiol 2002; 283:F1003-F1010.
15. Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, Navar LG. Ang ii accumulation in rat renal endosomes during ang II-induced hypertension: role of AT(1) receptor. Hypertension 2002; 39:116-121.
16. Kobori H, Harrison-Bernard LM, Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 2002; 61:579-585.
17. Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 2003; 41:42-49.
18. Suzaki Y, Ozawa Y, Kobori H. Quantification of human angiotensinogen by a novel sandwich ELISA. Peptides 2006; 27:3000-3002.
19. Mills KT, Kobori H, Hamm LL, Alper AB, Khan IE, Rahman M, et al. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol Dial Transplant 2012; 27: 3176-3181.
20. Kobori H, Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Yamamoto T. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney diseases. J Am Soc Hypertens 2008; 2:349-354.
21. Saito T, Urushihara M, Kotani Y, Kagami S, Kobori H. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci 2009; 338:478-480.
22. Yamamoto T, Nakagawa T, Suzuki H, Ohashi N, Fukasawa H, Fujigaki Y, et al. Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol 2007; 18:1558-1565.
23. Kobori H, Alper AB Jr, Shenava R, Katsurada A, Saito T, Ohashi N, et al. Urinary angiotensinogen as a novel biomarker of the intrarenal reninangiotensin system status in hypertensive patients. Hypertension 2009; 53:344-350.
24. Kobori H, Urushihara M, Xu JH, Berenson GS, Navar LG. Urinary angiotensinogen is correlated with blood pressure in men (Bogalusa heart study). J Hypertens 2010; 28:1422-1428.
25. Franco M, Martinez F, Quiroz Y, Galicia O, Bautista R, Johnson RJ, Rodriguez-Iturbe B. Renal angiotensin ii concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 2007; 293:R251-R256.
26. Kobori H, Nishiyama A, Abe Y, Navar LG. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 2003; 41:592-597.
27. Konishi Y, Nishiyama A, Morikawa T, Kitabayashi C, Shibata M, Hamada M, et al. Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy. Hypertension 2011; 58:205-211.
28. GenSalt Collaborative Research Group. Gensalt: rationale, design, methods and baseline characteristics of study participants. J Hum Hypertens 2007; 21:639-646.
29. Sullivan JM. Salt sensitivity. Definition, conception, methodology, and long-term issues. Hypertension 1991; 17:I61-68.
30. Perloff D, Grim C, Flack J, Frohlich ED, Hill M, McDonald M, Morgenstern BZ. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88:2460-2470.
31. Schunkert H, Ingelfinger JR, Jacob H, Jackson B, Bouyounes B, Dzau VJ. Reciprocal feedback regulation of kidney angiotensinogen and renin mRNA expressions by angiotensin II. Am J Physiol 1992; 263: E863-E869.
32. Kobori H, Harrison-Bernard LM, Navar LG. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 2001; 37:1329-1335.
33. Kobori H, Harrison-Bernard LM, Navar LG. Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 2001; 12:431-439.
34. Zhou A, Carrell RW, Murphy MP, Wei Z, Yan Y, Stanley PL, et al. A redox switch in angiotensinogen modulates angiotensin release. Nature 2010; 468:108-111.
35. Ohashi N, Katsurada A, Miyata K, Satou R, Saito T, Urushihara M, Kobori H. Activation of reactive oxygen species and the renin-angiotensin system in IgA nephropathy model mice. Clin Exp Pharmacol Physiol 2009; 36:509-515.
36. Kobori H, Nishiyama A. Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats. Biochem Biophys Res Commun 2004; 315:746-750.
37. Meng S, Cason GW, Gannon AW, Racusen LC, Manning RD Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 2003; 41:1346-1352.
38. Sharma AM, Schattenfroh S, Kribben A, Distler A. Reliability of saltsensitivity testing in normotensive subjects. Klin Wochenschr 1989; 67:632-634.
39. Draaijer P, de Leeuw P, Maessen J, van Hooff J, Leunissen K. Salt-sensitivity testing in patients with borderline hypertension: reproducibility and potential mechanisms. J Hum Hypertens 1995; 9:263-269.